Efficacy of Jiangsha Banxia nano-paste on nausea and vomiting in end-stage patients and its effect on QOL in cancer patients
10.12206/j.issn.2097-2024.202210049
- VernacularTitle:姜砂半夏纳米贴治疗疾病终末期患者恶心呕吐疗效及对肿瘤患者QOL影响
- Author:
Tianhong ZHANG
1
;
Xiufeng LIU
2
;
Hua WANG
1
;
Xiujuan DING
1
;
Haimin DAI
3
;
Ping HU
4
;
Weifeng WANG
5
;
Qing LU
6
;
Feng XU
2
;
Wanhong HE
1
Author Information
1. Shanghai Fengxian Guangming Community Health Center, Shanghai 201406, China.
2. Sixth People’s Hospital South District, Shanghai Jiao Tong University, Shanghai 201400, China.
3. Shanghai Fengxian Jinhui Community Health Center, Shanghai 201404, China.
4. Shanghai Fengxian Fengcheng Community Health Center, Shanghai 201411, China.
5. Shanghai Fengxian Zhuanghang Community Health Center, Shanghai 201415, China.
6. Shanghai Fengxian Fengpu Community Health Center, Shanghai 201401, China.
- Publication Type:Medicine&Clinical
- Keywords:
end-stage disease;
nausea;
vomiting;
Jiangsha Banxia nano-paste;
acupoint application;
external treatment
- From:
Journal of Pharmaceutical Practice
2023;41(6):380-384
- CountryChina
- Language:Chinese
-
Abstract:
Objective To observe the clinical efficacy of Jiangshabanxia nano-paste on nausea and vomiting in end-stage patients and its effect on the quality-of-life (QOL) in cancer patients. Methods 120 end-stage patients with nausea and vomiting symptoms above grade III were randomly divided into observation group and control group. They were treated with Jiangshabanxia nano-paste and placebo paste respectively. The paste patch was changed every 24 hours and used continuously for 7 days. The nausea and vomiting symptom score, the quality-of-life measurement score and KPS score of cancer patients in the two groups were observed to evaluate the curative effect. Results After 7 days of treatment, the symptom scores of nausea and vomiting in the observation group decreased significantly, the KPS score of the observation group increased, and the effective rate was higher than that in the control group. The score of QOL measurement showed that after treatment, the score of main symptom areas and other symptom areas (except external dyspnea, diarrhea and economic difficulties) in the observation group decreased, and the score of overall health area increased. After treatment, the score of main symptom areas and other symptom areas (except external dyspnea, diarrhea and economic difficulties) in the observation group was lower than that in the control group, and the scores of overall health area in the observation group were higher than those in the control group. Conclusion Jiangshabanxia nano-paste has a good clinical efficacy nausea and vomiting in end-stage patients, it also can improve the quality of life end-stage cancer patients.
